Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Universal Posaconazole Prophylaxis Versus Pre-emptive Posaconazole Therapy for Fungal Infection Management Post-lung Transplantation

NCT03561415 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT03561415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Universal Posaconazole Prophylaxis Versus Pre-emptive Posaconazole Therapy for Fungal Infection Management Post-lung Transplantation
Lead sponsor
Bayside Health
Phase
Phase 2
Overall status
Unknown status
Start date
July 2, 2018
Completion date
September 30, 2020
Enrollment
140 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fungal infection